It would seem that yet again Pfizer got the long straw as they landed the expansion they had been dreaming of. This win-win deal is bound to boost Pfizer’s vaccine business. By agreeing to pick up the vaccine portfolio Baxter owns (a portfolio worth $635 million), Pfizer has insured that they would be building their business up next year while the Deerfield based healthcare company will be … [Read more...]